Yancey is also Professor Emeritus of Neurosurgery at the University of Alabama Birmingham (UAB) with over 27 years' direct research experience with oncolytic HSV and G207. Yancey was instrumental in developing the protocols for the three previous G207 adult brain tumor trials. He has served as a Scientific Advisory Board Member for the American Brain Tumor Association, the Pediatric Brain Tumor Foundation, and currently serves as the chair of the Basic Research Review committee for the National Brain Tumor Society. Previously he co-directed the Neuro-Oncology Program and the Brain Tumor SPORE in the UAB O'Neal Comprehensive Cancer Center.
Sign up to view 0 direct reports
Get started